Learn how OzUK and Ab Initio Pharma can support your MDI development program using advanced characterisation tools

Written By PY

Download the document here, courtesy of Inhalation Magazine

Learn how OzUK and Ab Initio Pharma can support your MDI development program by providing advanced dissolution and characterisation tools that are critical for evaluating the equivalence of transitioning propellants

PY
Next

OzUK and Ab Initio support early stage clinical trials